Author

Luba K. Vujcic

Observed names: L K Vujcic, L Vujcic, L. K. Vujcic, L. Vujcic, LUBA K. VUJCIC, Luba Vujcic

Institutions: Center for Biologics Evaluation and Research, United States Food and Drug Administration

Observed institutions: National Institutes of Health, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Long Island Jewish Medical Center, Schneider Children's Hospital, Research Institute for Microbial Diseases, The University of Osaka, Stony Brook University, The University of Osaka

OpenAlex ID: A5034762458

Possible Beneficial Effects of Neutralizing Antibodies and Antibody-Dependent, Cell-Mediated Cytotoxicity in Human Immunodeficiency Virus Infection

1990 · Leigh A. Sawyer, David A. Katzenstein, et al. · AIDS Research and Human Retroviruses · 82

Preparation and Characterization of Human HIV Type 1 Neutralizing Reference Sera

1995 · LUBA K. VUJCIC, GERALD V. QUINNAN · AIDS Research and Human Retroviruses · 62

Mutations in both gp120 and gp41 Are Responsible for the Broad Neutralization Resistance of Variant Human Immunodeficiency Virus Type 1 MN to Antibodies Directed at V3 and Non-V3 Epitopes

1998 · Eun Ju Park, Luba K. Vujcic, et al. · Journal of Virology · 58

Five-Year Follow-up Study of Recipients of Live Varicella Vaccine Using Enhanced Neutralization and Fluorescent Antibody Membrane Antigen Assays

1983 · Yoshizo Asano, Paul Albrecht, et al. · PEDIATRICS · 56

High Prevalence of Antibodies to the gp120 V3 Region Principal Neutralizing Determinant of HIV-1 MN in Sera from Africa and the Americas

1991 · Emily W. Carrow, Luba K. Vujcic, et al. · AIDS Research and Human Retroviruses · 55

Re-evaluation of the Involvement of the Adhesion Molecules ICAM-1/LFA-1 in Syncytia Formation of HIV-1-Infected Subclones of a CEM T-Cell Leukemic Line

1991 · Marion F. Gruber, Deborah S. A. Webb, et al. · AIDS Research and Human Retroviruses · 40

Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.

1990 · K Hillman, O Shapira-Nahor, et al. · The Journal of Immunology · 40

Use of a Sensitive Neutralization Assay to Measure the Prevalence of Antibodies to the Human Immunodeficiency Virus

1988 · L. K. Vujcic, D. H. Shepp, et al. · The Journal of Infectious Diseases · 37

The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells

1994 · H Golding, J Manischewitz, et al. · Journal of Virology · 31

CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection

1990 · Orit Shapira-Nahor, Hana Golding, et al. · Cellular Immunology · 24

Human immunodeficiency virus neutralizing antibodies in sera from North Americans and Africans.

1990 · D A Katzenstein, L K Vujcic, et al. · PubMed · 20

Evaluation of humoral immunity to varicella-zoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test

1983 · Y. Asano, P. Albrecht, et al. · Archives of Virology · 15

Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus

1982 · J P Iltis, G A Castellano, et al. · Journal of Clinical Microbiology · 14

International Collaborative Study to Compare Assays for Antibodies that Neutralize Human Immunodeficiency Virus

1990 · L. Vujcic, D. Katzenstein, et al. · AIDS Research and Human Retroviruses · 13

Varicella-Zoster Virus-Specific HLA-Restricted Cytotoxicity of Normal Immune Adult Lymphocytes After in Vitro Stimulation

1988 · Ellen C. Cooper, Luba K. Vujcic, et al. · The Journal of Infectious Diseases · 13

Study of Viral Replication in HIV-1-Infected CEM T-Cell Subclones Which Are Reduced in Their Ability to Form Syncytia

1992 · Marion F. Gruber, Indira K. Hewlett, et al. · AIDS Research and Human Retroviruses · 1

Periodic development of neutralizing antibody responses to antigenic variants of human immunodeficiency virus

1990 · Gerald V. Quinnan, Luba K. Vujcic, et al. · Clinical research

Periodic changes in neutralization epitopes of hiv 1 involve variable region 3

1990 · Luba K. Vujcic, Emily Carrow, et al.

HTLV-III/LAV particle-associated proteins: I. Virus purification, inactivation and basic characterization

1987 · Michael Phelan, J. Willard Hall, et al. · Springer eBooks

Works count: 20

Citation count: 561

H-index: 13

I10-index: 15